Condition
Chemotherapy-induced Neutropenia clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Chemotherapy-induced Neutropenia clinical trials that are recruiting, at sites in 5 countries (most in China (4), Denmark (2), Germany (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 5Countries
Newest Chemotherapy-induced Neutropenia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Me capegfilgrastim to help prevent neutropenia in advanced breast cancer patients on chemotherapy | — | Hangzhou, Zhejiang | Recruiting | Oct 27, 2026 |
| Telpegfilgrastim to prevent neutropenia in people with solid tumors | — | Hefei, Anhui and 1 other locations | Recruiting | Jul 31, 2025 |
| Telpegfilgrastim versus filgrastim to prevent low white blood counts after chemotherapy in children and young adults | Phase 2 | Beijing | Recruiting | Apr 15, 2025 |
| Evaluating Telpegfilgrastim for preventing neutropenia in pediatric cancer patients undergoing chemotherapy | Phase 2 | Guangzhou, Guangdong | Recruiting | Mar 4, 2025 |
| Home monitoring of blood tests for cancer patients | — | Næstved, Region Sjælland and 4 other locations | Recruiting | Feb 5, 2025 |
| Breath analysis to detect fungal infections in leukemia patients | — | Zurich, Canton of Zurich | Recruiting | Aug 5, 2024 |
| Investigation of blood mutations in elderly lymphoma patients | — | Copenhagen | Recruiting | Feb 18, 2022 |
All recruiting trials (7)
-
Me capegfilgrastim to help prevent neutropenia in advanced breast cancer patients on chemotherapy
This real-world registry tests whether mecapegfilgrastim used with chemotherapy helps prevent low white blood cells in adults with advanced breast cancer.
-
Telpegfilgrastim to prevent neutropenia in people with solid tumors
This project will test whether telpegfilgrastim injections can prevent chemotherapy-related low neutrophil counts in adults with solid tumors who are at increased risk.
-
Telpegfilgrastim versus filgrastim to prevent low white blood counts after chemotherapy in children and young adults
This study tries to see if a single long‑acting injection of telpegfilgrastim can reduce febrile neutropenia compared with daily filgrastim in 6–24‑year‑olds receiving high‑intensity chemotherapy for solid tumors.
-
Evaluating Telpegfilgrastim for preventing neutropenia in pediatric cancer patients undergoing chemotherapy
This study is testing if a new drug called Telpegfilgrastim can help prevent low white blood cell counts in teenagers with cancer who are getting strong chemotherapy.
-
Home monitoring of blood tests for cancer patients
This study is testing if cancer patients can do their blood tests at home during chemotherapy to make things easier and improve their care.
-
Breath analysis to detect fungal infections in leukemia patients
This study is testing if analyzing breath samples can help doctors detect fungal infections in leukemia patients who are at high risk due to their treatment.
-
Investigation of blood mutations in elderly lymphoma patients
This study is testing how blood mutations affect older patients with B-cell Non-Hodgkin lymphoma during chemotherapy to see who might do better with standard treatments or newer options that have fewer side effects.
Related topics
Quick answers
How many Chemotherapy-induced Neutropenia clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (4 trials), Denmark (2 trials), Germany (1 trial), Poland (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.